In recent years, an approach called "chemical genetics" has been adopted in drug research to discover and validate new targets and to identify and optimize leads by high throughput screening. In this work, we tested the ability of a library of small peptidomimetics to induce phenotypic effects with functional implications on a panel of strains of the budding yeast Saccharomyces cerevisiae, both wild type and mutants, for respiratory function and multidrug resistance. Further elucidation of the function of these peptidomimetics was assessed by testing the effects of the compound with the most prominent inhibitory activity, 089, on gene expression using DNA microarrays. Pathway analysis showed the involvement of such a molecule in inducing oxidative damage through alterations in mitochondrial functions. Transcriptional experiments were confirmed by increased levels of ROS and activation of mitochondrial membrane potential. Our results demonstrate the influence of a functional HAP1 gene in the performance of S. cerevisiae as a model system.Pharmaceutical and biotechnological fields are constantly looking for new drugs characterized by innovation and economy (1). New approaches emerging from chemical and biological knowledge, such as "chemical genetics" (2), consist of the study of biological systems by systematic investigation of the effects of small molecules on a specific cellular model rather than perturbing with gene mutations (3-5). This new approach has been divided into forward and reverse chemical genetics; the former is based on the research of a desired phenotypic effect following the administration of small molecules to biological systems of interest, whereas the latter is based on the investigation of the effects of small molecules against a specific target (6 -8). To make these new approaches time-and moneysaving, the set-up of easy, rapid, and economical chemical synthesis and biological screening processes is essential (9, 10). The budding yeast Saccharomyces cerevisiae, which has been defined as an "honorary mammal" (11), is a suitable model organism for this aim, mainly because of the high degree of conservation with human cells concerning main biological processes (11). Thanks to its ease of manipulation, it can be successfully used to identify molecules of pharmacological interest (4, 12). Moreover, once active compounds have been selected, functional information about their mode of action can be inferred from screening ϳ5000 viable yeast haploid deletion mutant strains for hypersensitivity or hyperresistance to each molecule, thus identifying pathways that influence the cellular response to tested compounds (13-16). However, so far, chemical genetic approaches have used only one genetic background, that of laboratory strain S288c, which is limited by an accumulation of genetic defects, such as the inability to sustain proper respiratory metabolism of this strain (4,(17)(18)(19). In this work, we selected a panel of strains in which it is possible to investigate the influence of a library of mole...